L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease

作者：Cools R, Lewis SJ, Clark L, Barker RA, Robbins TW · 发表于：Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 年份：2007 · DOI：10.1038/sj.npp.1301153

Evidence indicates that dopaminergic medication in Parkinson's disease may impair certain aspects of cognitive function, such as reversal learning. We used functional magnetic resonance imaging in patients with mild Parkinson's disease to investigate the neural site at which L-DOPA acts during reversal learning. Patients were scanned both ON and OFF their normal dopamine-enhancing L-DOPA medication during the performance of a probabilistic reversal learning task. We demonstrate that L-DOPA modulated reversal-related activity in the nucleus accumbens, but not in the dorsal striatum or the prefrontal cortex. These data concur with evidence from studies with experimental animals and indicate an important role for the human nucleus accumbens in the dopaminergic modulation of reversal learning.